Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anna Schiattarella"'
Autor:
Elisa Lucchini, Chiara Rusconi, Mario Levis, Francesca Ricci, Armando Santoro, Umberto Ricardi, Stefano Volpetti, Fabio Matrone, Anna Di Russo, Manuela Caizzi, Anna Schiattarella, Francesco Zaja
Publikováno v:
Hematology Reports, Vol 13, Iss 2 (2021)
The rate of complete remission (CR) with the anti-PD1 immune checkpoint inhibitors (ICI) nivolumab (N) and pembrolizumab (P) in patients with relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) is low (20-30%), and the majority of patients eve
Externí odkaz:
https://doaj.org/article/35964a569f1b49e1b155084f149ad497
Autor:
Mehdi Astaraki, Mara Severgnini, Vittorino Milan, Anna Schiattarella, Francesca Ciriello, Mario de Denaro, Aulo Beorchia, Hossein Aslian
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 5, Iss , Pp 52-57 (2018)
Background and purpose: In radiation therapy, defining the precise borders of cancerous tissues and adjacent normal organs has a significant effect on the therapy outcome. Deformable models offer a unique and robust approach to medical image segmenta
Externí odkaz:
https://doaj.org/article/aff2a46222b542b3867c726d7ae2690a
Autor:
Manuela Caizzi, Elisa Lucchini, Francesco Zaja, Anna Schiattarella, Stefano Volpetti, Armando Santoro, Mario Levis, Chiara Rusconi, Francesca Ricci, Fabio Matrone, Umberto Ricardi, Anna Di Russo
Publikováno v:
Hematology Reports, Vol 13, Iss 2 (2021)
Hematology Reports
Hematology Reports; Volume 13; Issue 2; Pages: 9080
Hematology Reports
Hematology Reports; Volume 13; Issue 2; Pages: 9080
The rate of complete remission (CR) with the anti-PD1 immune checkpoint inhibitors (ICI) nivolumab (N) and pembrolizumab (P) in patients with relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) is low (20–30%), and the majority of patients e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9c3f8eaf05ebdaf599685cfd6041faa
https://www.pagepress.org/journals/index.php/hr/article/view/9080
https://www.pagepress.org/journals/index.php/hr/article/view/9080